Highlights on Advancing Frontiers in Tissue Engineering.
Nureddin AshammakhiAmin GhavamiNejadRumeysa TutarAnnabelle FrickerIpsita RoyXanthippi ChatzistavrouEhsanul Hoque ApuKim-Lien NguyenTaby AhsanIppokratis PountosEdward J CatersonPublished in: Tissue engineering. Part B, Reviews (2021)
The field of tissue engineering continues to advance, sometimes in exponential leaps forward, but also sometimes at a rate that does not fulfill the promise that the field imagined a few decades ago. This review is in part a catalog of success in an effort to inform the process of innovation. Tissue engineering has recruited new technologies and developed new methods for engineering tissue constructs that can be used to mitigate or model disease states for study. Key to this antecedent statement is that the scientific effort must be anchored in the needs of a disease state and be working toward a functional product in regenerative medicine. It is this focus on the wildly important ideas coupled with partnered research efforts within both academia and industry that have shown most translational potential. The field continues to thrive and among the most important recent developments are the use of three-dimensional bioprinting, organ-on-a-chip, and induced pluripotent stem cell technologies that warrant special attention. Developments in the aforementioned areas as well as future directions are highlighted in this article. Although several early efforts have not come to fruition, there are good examples of commercial profitability that merit continued investment in tissue engineering.